Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
06.1 Etiology
06.2 Epidemiology
06.3 Risk Factors
06.4 Quality of Life
06.5 Symptoms
06.6 Diagnosis
06.7 Management & Treatment
07. SLE Pipeline Landscape
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 SLE Drugs Market in the Americas
08.3.1 Market Size and Forecast
08.4 SLE Drugs Market in Europe
08.4.1 Market Size and Forecast
09. Market Assessment of Benlysta
09.1.1 Benlysta Revenue Forecast in the US
09.1.2 Benlysta Revenue Forecast in 5EU
09.2 Five Forces Analysis
10. Market Segmentation by Type
11. Market Segmentation by Therapeutic Class
12. Geographical Segmentation
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Anthera Pharmaceuticals
20.2.2 BMS
20.2.3 GSK
20.2.4 ImmuPharma
20.2.5 UCB
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Anthera Pharmaceuticals
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Strategy
21.1.4 Recent Developments
21.1.5 SWOT Analysis
21.2 Bristol-Myers Squibb Co.
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Key Product Offerings
21.2.4 Revenue by Geography
21.2.5 Business Strategy
21.2.6 Key Information
21.2.7 SWOT Analysis
21.3 GlaxoSmithKline
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Sales by Geography
21.3.6 Pipeline Products
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 ImmuPharma
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Strategy
21.4.4 Recent Developments
21.4.5 SWOT Analysis
21.5 Merck Serono
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Geographical Segmentation by Revenue 2013
21.5.4 Business Strategy
21.5.5 Recent Developments
21.5.6 SWOT Analysis
21.6 UCB
21.6.1 Key Facts
21.6.2 Business Overview
21.6.3 Product Segmentation by Revenue 2013
21.6.4 Product Segmentation by Revenue 2012 and 2013
21.6.5 Geographical Segmentation by Revenue 2013
21.6.6 Business Strategy
21.6.7 Recent Developments
21.6.8 SWOT Analysis
22. Other Reports in this Series

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

• Manufacturers and suppliers
• Channel partners
• Industry experts
• Strategic decision makers

Secondary sources

• Industry journals and periodicals
• Government data
• Financial reports of key industry players
• Historical data
• Press releases

DATA ANALYSIS

Data Synthesis

• Collation of data
• Estimation of key figures
• Analysis of derived insights

Data Validation

• Triangulation with data models
• Reference against proprietary databases
• Corroboration with industry experts

REPORT WRITING